Introduction

RUSSIAN REGISTRY OF PATIENTS WITH TUMORS OF THE HYPOTHALAMIC-PITUITARY REGION (OGGO): OCTOBER 2013 UPDATE FOR ACROMEGALY
Materials and methods
The largest part of registered patients constitutes patients with acromegaly (53%), followed by patients with prolactinomas (26%), inactive pituitary tumors (9%), Cushing's disease (6%), mixed secretion pituitary tumors (4%), and other tumors (2%). Among 2781 patients with acromegaly 72% are women. Peak incidence is between the ages of 40-50 years. 1% of patients have got first (highest) degree of disability, 18% -second degree and 13% -third degree. 57% of acromegalic patients do not have updated disease status, only 6% of patients have remission, 7% partial remission and 30% are in the active state of the disease. Hypopituitarism is present in 9% of patients, visual disturbances in 16% and neurologic complications in 63% (e.g. headaches -87.5%, carpal tunnel syndrome -5%, ptosis -3.7%, vertigo -2.7%, diplopia -0.9%). Surgery was performed in 33.1% of patients, 17% received radiation therapy and 49% -drug therapy (octreotide long acting -28%, lanreotide long acting -2.6%, bromocriptine -24%, cabergoline -5.6%, with about 9% of patients receiving combination therapy of dopamine agonists and somatostatin analogs).
Acromegaly is a highly disabling disease. Our database show low implementation of surgical and specific drug treatment among acromegalic patients.
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There are overall 5340 patients registered in the OGGO from 2004 to 2013. 
